EVMS Home Secondary Page Menubar
Department Information
Education
Research
Faculty
* Peter F. Blackmore, PhD
* William J. Cooke, PhD
* Yuliya Dobrydneva, PhD
* Alireza Hosseini, M.D.
* Frank A. Lattanzio, PhD
* Patricia B. Williams, PhD
Staff and Students

Biochemistry
Physiology

Pharmacology

Alireza Hosseini, M.D.Faculty

Alireza Hosseini, M.D.
Instructor

Lewis Hall, 3027
Office: (757) 446-5634
Lab: (757) 446-5732
Email: hosseia@evms.edu

Professional Experiences

  • Pharmacology Instructor, Department of Physiological Sciences, Eastern Virginia Medical School, 2007-present
  • Ocular Pharmacology Fellow, Department of Physiological Sciences, Eastern Virginia Medical School, 2003-2007
  • General Practitioner, Ankara, Turkey 1999-2000

Education

  • M.D., Hacettepe University, Faculty of Medicine, Ankara, Turkey, 1999

Research Interests:

Ocular Pharmacology including:

  • Ocular Pharmacology including treatment for glaucoma, AMD, dry eye and cornea transplant
  • Development of a new device to monitor and treat glaucoma
  • Development of animal models for ocular pharmacology evaluations

Honors and Awards

  • ISOV award for best ARVO abstract (2007)
  • Young Scientist Travel Award for the ASPET annual meeting at Experimental Biology (2006)
  • Travel award - Best poster presentation - Cardiovascular/Renal focal group for Eastern Virginia Medical School Research Day (2004)

Society Memberships

  • American Society for Pharmacology and Experimental Therapeutics (ASPET) 2005-present
  • Iranian Society of Ophthalmology and Vision Scientists (ISOV) 2004-present
  • The Association for Research in Vision and Ophthalmology (ARVO) 2003-present

Publications

Oltmanns MH, Samudre SS, Castillo IG, Hosseini A, Lichtman AH, Allen RC, Lattanzio FA, Williams PB. Topical WIN 55-212-2 Alleviates Intraocular Hypertension in Rats through a CB1 Receptor Mediated Mechanism of Action. J Ocular Pharmcol Ther. 2008 Feb:24(1):104-15.

Hosseini, A.,  Lattanzio, F.A., Williams, P.B., Tibbs, D., Samudre, S.S., and Allen, R.C. (2006) Chronic topical administration of WIN-55-212-2 maintains a reduction of IOP in a rat glaucoma model without adverse effects. Exp Eye Res, Volume 82, Issue 5, Pages 753-759.

Top

Home / Site Map / Search / About EVMS / Patient Services
Education / Research / Departments / Library

Feedback / Copyright © 1999-2008 Eastern Virginia Medical School
Revised: May 23, 2008